Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

11 treatments under study, led by Normal Saline Placebo For Bupivacaine

Research Leaders

9 sponsors active, led by Health Service Executive

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 8 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

29%

2 of 7 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (5)
Phase 4 (1)

Trial Status

Completed7
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 7 completed trials

Clinical Trials (8)

Research Network

Common Treatments

  • Normal Saline Placebo For Bupivacaine1
  • Nponone Per Oral1
  • Bupivacaine1
  • Proficiencybased Virtual Reality Simulation Training1
  • Laparoscopic Colectomy1

Active Sponsors

  • Health Service Executive1
  • Shanghai Changzheng Hospital1
  • University of Surrey1
  • University Hospitals Cleveland Medical Center1
  • Royal College of Surgeons, Ireland1

Top Investigators

Related Conditions

  • Stress Response1
  • Digestive Tract Diseases1
  • Liver Diseases1
  • Gastric Diseases1
  • Gastrointestinal Disease1

Activity Timeline